Logo image
Sign in
JAK inhibitors in autoinflammatory syndromes? The long road from drug development to daily clinical use
Journal article   Open access

JAK inhibitors in autoinflammatory syndromes? The long road from drug development to daily clinical use

Philippe Guilpain
Rheumatology, Vol.62(4), pp.1368-1369
01/04/2023
PMID: 36218416

Abstract

Humans Janus Kinase Inhibitors Syndrome Arthritis, Juvenile Drug Development Still's Disease, Adult-Onset
This editorial refers to the article ‘JAK inhibitors in difficult-to-treat adult-onset Still’s disease and systemic-onset juvenile idiopathic arthritis’, published by Gillard L. et al., 2023;62: 1594–1604.
url
Find in HALView
url
https://doi.org/10.1093/rheumatology/keac592View
Published (Version of record) Open

Metrics

1 Record Views

Details

Logo image